Oncology
News
FDA OKs selpercatinib for adults with RET-fusion+ solid tumors
In 2020, selpercatinib received accelerated approval for lung and thyroid RET-positive tumors.
From the Journals
Pandemic-related CRC screening delays affect older adults most
Since previously unscreened 65-year-olds lose the most benefit from delayed colorectal cancer screenings, they should be prioritized when access...
Conference Coverage
High BMI linked to better survival for cancer patients treated with ICI, but for men only
The reasons behind the findings and implications for treatment are unknown, as is whether it applies to patients with specific cancers.
Conference Coverage
Sotorasib superior to docetaxel in KRAS G12C–mutated NSCLC
In its first randomized, phase 3 comparison trial, the first-in-class agent sotorasib held its own against the standard of care docetaxel.
From the Journals
Early trial supports hypofractionated radiotherapy in uterine cancer
Early toxicity results are encouraging, but long-term efficacy and safety remain unknown.
From the Journals
Sugary drinks linked to obesity-related cancer deaths
In addition, consuming artificially sweetened beverages was linked to an increased risk of death from pancreatic cancer.
Latest News
Experts sound alarm on ruling threatening preventive cancer care
Experts are concerned that the ruling will force some individuals to pay out of pocket for preventive cancer screenings.
Latest News
Novel blood test for early-stage liver cancer shows promise
Latest News
Atezolizumab doubles survival of NSCLC patients with poor performance status
Patients typically excluded from clinical trials because of age or comorbidities had better survival with atezolizumab than single-agent...
Conference Coverage
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional...
Latest News
Biden’s Cancer Moonshot turns its focus to early-detection blood tests
If these tests become standard, the oncology field will need to navigate a thicket of new challenges.